Abstract
Celastraceae species have a long tradition of use in folk medicine and agriculture. Intensive research into this family has resulted in the isolation of a large number of secondary metabolites with a wide range of bioactivity, with the most characteristic being the dihydro-β-agarofuran sesquiterpenes and the quinomethide triterpenoids. Despite diterpenoids not often being found in Celastraceae species, the novelty of their structures and their biological activities has stimulated their research. There are several reviews covering studies on Tripterigium wilfordii, a traditional Chinese medicine, and their metabolites, but none focusing on bioactive diterpenoids isolated from other Celastraceae species. This review focuses on diterpenes isolated from Celastraceae species, and their skeleton diversity, species sources, and tested biological activities are discussed. The literature from January 2000 to October 2016 is reviewed, and 64 references are cited. A total of 118 isolated diterpenoids possessing twelve different skeletons are included and classified by the following tested biological activity: cytotoxicity, anti-inflammatory, antitumour-promotion, anti-HIV, immunosuppressant, reversal multi-drug resistance, and antifeedant. This compliance information will be helpful in further research into diterpene Celastraceae isolation, biological activity determination and structure specific modifications.
Similar content being viewed by others
References
Alvarenga N, Ferro EA (2006) Bioactive triterpenes and related compounds from celastraceae. In: Atta-ur-Rahman (ed) Studies in natural products chemistry, vol 33. Elsevier, Amsterdam, pp 239–307
Ankli A, Heilmann J, Heinrich M, Sticher O (2000) Cytotoxic cardenolides and antibacterial terpenoids from Crossopetalum gaumeri. Phytochemistry 54:531–537
Brinker AM, Ma J, Lipsky PE, Raskin I (2007) Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae). Phytochemistry 68:732–766
Callies O, Sánchez-Carrete MP, Gamarro F et al (2016) Optimization by molecular fine tuning of dihydro-β-agarofuran sesquiterpenoids as reversers of P-glycoprotein-mediated multidrug resistance. J Med Chem 59:1880–1890
Chen B, Duan H, Takaishi Y (1999) Triterpene caffeoyl esters and diterpenes from Celastrus stephanotifolius. Phytochemistry 51:683–687
Dhillon S (2014) Trastuzumab emtansine: a review of its use in patients with her2-positive advanced breast cancer previously treated with trastuzumab-based therapy. Drugs 74:675–686
Duan H, Takaishi Y, Momota H et al (2001) Immunosuppressive terpenoids from extracts of Tripterygium wilfordii. Tetrahedron 57:8413–8424
Gao J-M, Wu W-J, Zhang J-W et al (2007) The dihydro-β-agarofuran sesquiterpenoids. Nat Prod Rep 24:1153
Gao C, Wang D, Zhang Y et al (2016) Kaurane and abietane diterpenoids from the roots of Tripterygium wilfordii and their cytotoxic evaluation. Bioorg Med Chem Lett 26:2942–2946
González AG, Bazzocchi IL, Gutiérrez Luis J et al (1986) Isopimaradiene diterpenes from Rzedowskia tolantonguensis. J Chem Res (Synopsis) 12:442–446
González AG, Alvarenga NL, Bazzocchi IL et al (1999) Triterpene trimers from Maytenus scutioides: cycloaddition compounds? J Nat Prod 62:1185–1187
González AG, Bazzocchi IL, Moujir L, Jiménez IA (2000) Ethnobotanical uses of Celastraceae. Bioactive metabolites. In: Atta-ur-Rahman (ed) Studies in natural products chemistry, vol 23. Elsevier, Amsterdam, pp 649–738
González AG, Kennedy ML, Rodríguez FM et al (2001) Absolute configuration of triterpene dimers from Maytenus species (Celastraceae). Tetrahedron 57:1283–1287
Gunatilaka AAL (1996) Triterpenoid quinonemethides and related compounds (celastroloids). In: Atta-ur-Rahman (ed) Progress in the chemistry of organic natural product, vol 67. Elsevier, Amsterdam, pp 1–123
Halaby R (2014) Novel anticancer agent for chemoresistant cancer cells that are caspase-3 deficient. J Mol Biol Mol Imaging 1(3):8
Han R, Rostami-Yazdi M, Gerdes S, Mrowietz U (2012) Triptolide in the treatment of psoriasis and other immune-mediated inflammatory diseases. Br J Clin Pharmacol 74:424–436
Heywood VH, Brummit RK, Culham A (2007) Flowering plants of the world. Editors-Oxford University Press, New York
Inaba Y, Hasuda T, Hitotsuyanagi Y et al (2013) Abietane diterpenoids and a sesquiterpene pyridine alkaloid from Euonymus lutchuensis. J Nat Prod 76:1085–1090
Jiménez-Estrada M, Reyes-Chilpa R, Hernández-Ortega S et al (2000) Two novel Diels–Alder adducts from Hippocratea celastroides roots and their insecticidal activity. Can J Chem 78:248–254
Kennedy ML, Llanos GG, Castanys S et al (2011) Terpenoids from Maytenus species and assessment of their reversal activity against a multidrug-resistant Leishmania tropica line. Chem Biodivers 8:2291–2298
Koyama Y, Matsunami K, Otsuka H et al (2010) Microtropiosides A–F: ent-labdane diterpenoid glucosides from the leaves of Microtropis japonica (Celastraceae). Phytochemistry 71:675–681
Kupchan SM, Komoda Y, Thomas GJ, Hintz HPJ (1972) Maytanprine and maytanbutine, new antileukaemic ansa macrolides from Maytenus buchananii. J Chem Soc Chem Commun 19:1065
Kusari S, Lamshöft M, Kusari P et al (2014) Endophytes are hidden producers of maytansine in Putterlickia roots. J Nat Prod 77:2577–2584
Lawrence T, Willoughby DA, Gilroy DW (2002) Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol 2:787–795
Li BL, Shen Q, Jin MN, Duan HQ (2010) Two new terpenes from Tripterygium wilfordii. Chin Chem Lett 21:827–829
Li XJ, Jiang ZZ, Zhang LY (2014) Triptolide: progress on research in pharmacodynamics and toxicology. J Ethnopharmacol 155:67–79
Li H-M, Wan D-W, Li R-T (2015a) New abietane-type diterpene glycosides from the roots of Tripterygium wilfordii. J Asian Nat Prod Res 17:761–766
Li XL, Gao LH, Li HM et al (2015b) Diterpenoids from the stems of Tripterygium hypoglaucum (Celastraceae) and cytotoxic evaluation. Phytochem Lett 12:84–89
Lin S, Que H, Peng H, Qian L, Guo S, Li Y (2011) Diterpene constituents of Tripterygium wilfordii (II). Acta Pharm Sin 46:942–945
Liu Q (2011) Triptolide and its expanding multiple pharmacological functions. Int Immunopharmacol 11:377–383
Ma J, Dey M, Yang H et al (2007) Anti-inflammatory and immunosuppressive compounds from Tripterygium wilfordii. Phytochemistry 68:1172–1178
Martín JD (1973) New diterpenoids extractives of Maytenus dispermus. Tetrahedron 29:2553–2559
Mehta RG, Murillo G, Naithani R, Peng X (2010) Cancer chemoprevention by natural products: how far have we come? Pharm Res 27:950–961
Mirón-López G, Bazzocchi IL, Jiménez-Díaz IA et al (2014) Cytotoxic diterpenes from roots of Crossopetalum gaumeri, a Celastraceae species from Yucatan Peninsula. Bioorg Med Chem Lett 24:2105–2109
Muñoz O, Penaloza A, González AG et al (1996) The Celastraceae from Latin America. chemistry and biological activity. In: Atta-ur-Rahman (ed) Studies in natural products chemistry, vol 18. Elsevier, Amsterdam, pp 739–783
Naila A, Zhang YF (2015) Triptolide: a critical review on antiangiogenesis in cancer and scope in therapeutics. J Biomim Biomater Biomed Eng 23:37–46
Nasir S, Bukhari A, Jantan I, Seyed MA (2015) Effects of plants and isolates of Celastraceae family on cancer pathways. Anticancer Agents Med Chem 15:681–693
Newman DJ, Cragg GM (2016) Natural products as sources of new drugs from 1981 to 2014. J Nat Prod 79:629–661
Ni L, Ma J, Li CJ et al (2015) Novel rearranged and highly oxygenated abietane diterpenoids from the leaves of Tripterygium wilfordii. Tetrahedron Lett 56:1239–1243
Núñez MJ, Reyes CP, Jiménez IA et al (2011) ent-Rosane and abietane diterpenoids as cancer chemopreventive agents. Phytochemistry 72:385–390
Pan J (2010) RNA polymerase—an important molecular target of triptolide in cancer cells. Cancer Lett 292:149–152
Peters RJ (2010) Two rings in them all: the labdane-related diterpenoids. Nat Prod Rep 27:1521–1530
Qui D, Kao PN (2003) Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f. Drugs R&D 4:1–18
Rodríguez FM, López MR, Jiménez IA et al (2005) New phenolic triterpenes from Maytenus blepharodes. Semisynthesis of 6-deoxoblepharodol from pristimerin. Tetrahedron 61:2513–2519
Shen Q, Zhi Y, Takaishi Y et al (2008) Immunosuppressive terpenoids from Tripterygium wilfordii. Chin Chem Lett 19:453–456
Simmons MP, Cappa JJ, Archer RH et al (2008) Phylogeny of the Celastreae (Celastraceae) and the relationships of Catha edulis (qat) inferred from morphological characters and nuclear and plastid genes. Mol Phylogenet Evol 48:745–757
Singh IP, Bodiwala HS (2010) Recent advances in anti-HIV natural products. Nat Prod Rep 27:1781–1800
Spivey AC, Weston M, Woodhead S (2002) Celastraceae sesquiterpenoids: biological activity and synthesis. Chem Soc Rev 31:43–59
Swingle WT, Haller HL, Siegler EH, Swingle MC (1941) A chinese insecticidal plant, Tripterygium wilfordii, introduced into the United States. Science 93:60–61
Tanaka N, Ooba N, Duan H et al (2004) Kaurane and abietane diterpenoids from Tripterygium doianum (Celastraceae). Phytochemistry 65:2071–2076
Tang W, Zuo J (2012) Immunosuppressant discovery from Tripterygium wilfordii Hook f: the novel triptolide analog (5R)-5-hydroxytriptolide (LLDT-8). Acta Pharmacol Sin 33:1112–1118
Tantillo DJ (2011) Biosynthesis via carbocations: theoretical studies on terpene formation. Nat Prod Rep 28:1035–1053
Wang KW, Mao JS, Tai YP, Pan YJ (2006) Novel skeleton terpenes from Celastrus hypoleucus with anti-tumor activities. Bioorganic Med Chem Lett 16:2274–2277
Wang C, Li C-J, Ma J et al (2015) Bioactive 18(4 → 3)-abeo-abietanoid derivatives from the leaves of Tripterygium wilfordii. RSC Adv 5:30046–30052
William WN, Heymach JV, Kim ES, Lippman SM (2009) Molecular targets for cancer chemoprevention. Nat Rev Drug Discov 8:213–225
Xiong Y, Wang K, Pan Y et al (2006) Isolation, synthesis, and anti-tumor activities of a novel class of podocarpic diterpenes. Bioorg Med Chem Lett 16:786–789
Xu R, Fidler JM, Musser JH (2005) Bioactive compounds from Tripterygium wilfordii. In: Atta-ur-Rahnman (ed) Studies in natural products chemistry, vol 32. Elsevier, Amsterdam, pp 773–801
Xu J, Lu J, Sun F et al (2011) Terpenoids from Tripterygium wilfordii. Phytochemistry 72:1482–1487
Yao Z, Gao W, Yoshihisa T, Duan H (2007) Diterpenoid compounds from Tripterygium wilfordii and their anti-cancer activities. Chin Tradic Herb Drugs 38:1603–1616
Zhang Y-W, Fan Y-S, Wang X-D, Gao W-Y, Duan H-Q (2007) Diterpenoids possessed immunosuppressive activity from Tripterygium hypoglaucum. Chin Tradic Herb Drugs 38:493–496
Zhao P, Wang H, Jin DQ et al (2014) Terpenoids from Tripterygium hypoglaucum and their inhibition of LPS-induced NO production. Biosci Biotechnol Biochem 78:370–373
Zheng Y, Zhang WJ, Wang XM (2013) Triptolide with potential medicinal value for diseases of the central nervous system. CNS Neurosci Ther 19:76–82
Zhou Z-L, Yang Y-X, Ding J et al (2012) Triptolide: structural modifications, structure–activity relationships, bioactivities, clinical development and mechanisms. Nat Prod Rep 29:457
Zi J, Mafu S, Peters RJ (2014) To gibberellins and beyond! Surveying the evolution of (di)terpenoid metabolism. Annu Rev Plant Biol 65:259–286
Ziaei S, Halaby R (2016) Immunosuppressive, anti-inflammatory and anti-cancer properties of triptolide: a mini review. Avicenna J Phytomedicine 6:149–164
Acknowledgements
This study was supported by the Fundación CajaCanarias SALUCAN03 and SAF2015-65113-C2-1-R MINECO, Spain projects, and by FEDER funds from the EU.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bazzocchi, I.L., Núñez, M.J. & Reyes, C.P. Bioactive diterpenoids from Celastraceae species. Phytochem Rev 16, 861–881 (2017). https://doi.org/10.1007/s11101-017-9494-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11101-017-9494-4